Statin-induced myopathy

Research output: Contribution to journalArticle

Abstract

Statins are widely used for primary and secondary prevention of cardiovascular disease. Several large clinical trials have demonstrated that by lowering LDL-cholesterol clinical events (eg myocardial infarction, stroke, and vasuclar death) can be reduced when statins are commenced in most patients without contraindications who have established cardiovascular disease.
Original languageEnglish
Pages (from-to)66-71
Number of pages6
JournalAustralian Pharmacist
Volume32
Issue number11
Publication statusPublished - 2013

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Muscular Diseases
Cardiovascular Diseases
Primary Prevention
Secondary Prevention
LDL Cholesterol
Stroke
Myocardial Infarction
Clinical Trials

Cite this

NAUNTON, Mark. / Statin-induced myopathy. In: Australian Pharmacist. 2013 ; Vol. 32, No. 11. pp. 66-71.
@article{5c396a5371e8448e8dcbf9d60342d8ba,
title = "Statin-induced myopathy",
abstract = "Statins are widely used for primary and secondary prevention of cardiovascular disease. Several large clinical trials have demonstrated that by lowering LDL-cholesterol clinical events (eg myocardial infarction, stroke, and vasuclar death) can be reduced when statins are commenced in most patients without contraindications who have established cardiovascular disease.",
keywords = "Statins, cardiovascular disease, clinical trials, cholesterol, myopathy, stroke",
author = "Mark NAUNTON",
year = "2013",
language = "English",
volume = "32",
pages = "66--71",
journal = "Australian Pharmacist",
issn = "0728-4632",
number = "11",

}

NAUNTON, M 2013, 'Statin-induced myopathy', Australian Pharmacist, vol. 32, no. 11, pp. 66-71.

Statin-induced myopathy. / NAUNTON, Mark.

In: Australian Pharmacist, Vol. 32, No. 11, 2013, p. 66-71.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Statin-induced myopathy

AU - NAUNTON, Mark

PY - 2013

Y1 - 2013

N2 - Statins are widely used for primary and secondary prevention of cardiovascular disease. Several large clinical trials have demonstrated that by lowering LDL-cholesterol clinical events (eg myocardial infarction, stroke, and vasuclar death) can be reduced when statins are commenced in most patients without contraindications who have established cardiovascular disease.

AB - Statins are widely used for primary and secondary prevention of cardiovascular disease. Several large clinical trials have demonstrated that by lowering LDL-cholesterol clinical events (eg myocardial infarction, stroke, and vasuclar death) can be reduced when statins are commenced in most patients without contraindications who have established cardiovascular disease.

KW - Statins

KW - cardiovascular disease

KW - clinical trials

KW - cholesterol

KW - myopathy

KW - stroke

M3 - Article

VL - 32

SP - 66

EP - 71

JO - Australian Pharmacist

JF - Australian Pharmacist

SN - 0728-4632

IS - 11

ER -